GGrantIndex
Sort

40,608 grants matching prostate cancer

Bone matrix proteins in prostate cancer progression

$305,244
Pradip Roy-Burman · University Of Southern California · R01 · FY2007 · CA

Bone matrix proteins in prostate cancer progression

$305,244
Pradip Roy-Burman · University Of Southern California · R01 · FY2009 · CA

Bone matrix proteins in prostate cancer progression

$305,244
Pradip Roy-Burman · University Of Southern California · R01 · FY2008 · CA

Protease Activated Receptors in Cancer Invasion

$305,243
Lidija Covic · Tufts Medical Center · R01 · FY2009 · CA

Protease Activated Receptors in Cancer Invasion

$305,243
Lidija Covic · Tufts Medical Center · R01 · FY2007 · CA

Protease Activated Receptors in Cancer Invasion

$305,243
Lidija Covic · Tufts Medical Center · R01 · FY2008 · CA

MicroRNAs in African American Prostate Cancer

$305,233
Deepak Kumar · North Carolina Central University · U01 · FY2019 · CA

AR Gene Rearrangements and AR Signaling in Prostate Cancer

$305,177
Scott M. Dehm · University Of Minnesota · R01 · FY2014 · CA

Descriptive Studies and Record Linkage

$305,167
William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

ANDROGEN-DEPENDENT MTORC1 ACTIVATION IN ADVANCED ANDROGEN RECEPTOR (AR) INDEPENDENT PROSTATE CANCER

$305,158
The Cleveland Clinic Foundation · · FY2020 · Defense Health Agency

Suppression of Androgen Receptor by PTEN

$305,156
University Of Rochester · R01 · FY2002 · DK

Core 2: Recruitment and Retention Shared Resource Core

$305,144
Maria Pisu · University Of Alabama At Birmingham · P01 · FY2018 · CA

Targeting aggressive prostate cancer with novel theranostic nanomedicine

$305,137
Jer-Tsong Hsieh · Ut Southwestern Medical Center · R01 · FY2013 · CA

Androgen Signaling in prostate cancer progression and CRPC development

$305,119
Zijie Sun · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA

Cellular Trans. by Retrotransposon-Adenovirus Hybrid Ve.

$305,095
University Of California Los Angeles · R01 · FY2005 · CA

Role of and Epithelial Ets Factor in Breast Cancer

$305,030
Dennis K Watson · Medical University Of South Carolina · P01 · FY2007 · CA

ROLES OF INFLAMMATION AND ANDROGEN METABOLISM IN PROSTATE CANCER DISPARITY

$305,030
Ricardo Richardson · North Carolina Central University · P20 · FY2011 · MD

Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression

$305,025
Sooryanarayana Varambally · University Of Alabama At Birmingham · R01 · FY2016 · CA

Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression

$305,025
Sooryanarayana Varambally · University Of Alabama At Birmingham · R01 · FY2015 · CA

An Integrated Nano-Cell Delivery Platform of Theranostics for Lung Cancers

$305,025
Shyam S Mohapatra · University Of South Florida · R01 · FY2010 · CA

Regulation of Polycomb Repressive Complex 1 by EZH2 Regulated microRNAs in Cancer

$305,025
Sooryanarayana Varambally · University Of Alabama At Birmingham · R01 · FY2015 · CA

A NOVEL ENDOCRINE DISRUPTING AGENT AND BREAST CANCER

$305,024
Barry Matthew Markaverich · Baylor College Of Medicine · R01 · FY2007 · ES

SBIR Phase I: AI-Powered Prostate MRI Analysis Software

$305,000
Ray Fujita · Segmedix, Co. · · FY2025 · TIP

SBIR Phase I: Developing Next-Generation Payloads for Targeted Therapies

$305,000
Mengdie Wang · Redpoint Oncology, Inc. · · FY2025 · TIP

Genomic and Non-Genomic Effects of IGFBP-3 on Apoptosis

$305,000
University Of California Los Angeles · R01 · FY2002 · AG